rxstatShortages › Lisinopril

Lisinopril shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Lisinopril products are in shortage in Canada (6 of 39 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
Products affected
6 / 39
In shortage since
Dec 12, 2023
Reports on file
119
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
LISINOPRIL
10MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02386240 · since Aug 10, 2024, no end estimate · Shortage of an active ingredient.
Active shortage
LISINOPRIL
20MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02386259 · since Aug 10, 2024, no end estimate · Shortage of an active ingredient.
Active shortage
LISINOPRIL
5MG · TABLET · SIVEM PHARMACEUTICALS ULC
DIN 02386232 · since Mar 21, 2025, no end estimate · Shortage of an active ingredient.
Active shortage
APO-LISINOPRIL
5MG · TABLET · APOTEX INC
DIN 02217481 · since Jan 28, 2025, no end estimate · Shortage of an active ingredient.
Active shortage
APO-LISINOPRIL
10MG · TABLET · APOTEX INC
DIN 02217503 · since Dec 12, 2023, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-LISINOPRIL
20MG · TABLET · APOTEX INC
DIN 02217511 · since Apr 2, 2024, no end estimate · Shortage of an active ingredient.
Resolved
ZESTRIL
5MG · TABLET · SEARCHLIGHT PHARMA INC
DIN 02049333 · ended Jan 15, 2026 · Disruption of the manufacture of the drug.
Resolved
ZESTRIL
10MG · TABLET · SEARCHLIGHT PHARMA INC
DIN 02049376 · ended Dec 31, 2025 · Delay in shipping of the drug.
Resolved
AURO-LISINOPRIL
20MG · TABLET · AURO PHARMA INC
DIN 02394499 · ended Jan 7, 2026 · Demand increase for the drug.
Resolved
AURO-LISINOPRIL
5MG · TABLET · AURO PHARMA INC
DIN 02394472 · ended Jan 7, 2026 · Demand increase for the drug.
Resolved
TEVA-LISINOPRIL (TYPE Z)
5MG · TABLET · TEVA CANADA LIMITED
DIN 02285118 · ended Nov 25, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-LISINOPRIL (TYPE Z)
10MG · TABLET · TEVA CANADA LIMITED
DIN 02285126 · ended Aug 7, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Lisinopril is currently affected by 6 active shortage reports filed with Health Canada by SIVEM PHARMACEUTICALS ULC, APOTEX INC.

The reported causes are: shortage of an active ingredient; disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Lisinopril is classified under “ACE INHIBITORS, PLAIN” (ATC C09AA).

Recent changes

Common questions

When will Lisinopril be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Lisinopril in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (ace inhibitors, plain)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.